About Regenfro Co
Regenfro Co is a company based in Kyoto (Japan) founded in 2019 by Kenji Osafune.. Regenfro Co has raised $28.88 million across 2 funding rounds from investors including Sumitomo Mitsui Banking Corporation, MITSUI CHEMICALS and Shimadzu Corporation. Regenfro Co operates in a competitive market with competitors including Esprit Pharma, Lipella, Kissei Pharmaceutical, NEXT Life Sciences and TheraVida, among others.
- Headquarter Kyoto, Japan
- Founders Kenji Osafune
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$28.88 M (USD)
in 2 rounds
-
Latest Funding Round
$16.8 M (USD), Series B
Oct 07, 2024
-
Investors
Sumitomo Mitsui Banking Corporation
& 20 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Regenfro Co
Regenfro Co has successfully raised a total of $28.88M across 2 strategic funding rounds. The most recent funding activity was a Series B round of $16.8 million completed in October 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 2
- Last Round Series B — $16.8M
-
First Round
First Round
(31 Jan 2022)
- Investors Count 21
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Oct, 2024 | Amount | Series B - Regenfro Co | Valuation | Daiwa Corporate Investment , JIC Venture Growth Investments |
|
| Jan, 2022 | Amount | Series A - Regenfro Co | Valuation | Mitsubishi UFJ Capital , Kyoto University Innovation Capital |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Regenfro Co
Regenfro Co has secured backing from 21 investors, including venture fund and institutional investors. Prominent investors backing the company include Sumitomo Mitsui Banking Corporation, MITSUI CHEMICALS and Shimadzu Corporation. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital services are provided to support startups and innovation.
|
Founded Year | Domain | Location | |
|
Venture capital fund focused on growth stage companies
|
Founded Year | Domain | Location | |
|
VC firm investing in Japan and the US
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Regenfro Co
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Regenfro Co
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Regenfro Co Comparisons
Competitors of Regenfro Co
Regenfro Co operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Esprit Pharma, Lipella, Kissei Pharmaceutical, NEXT Life Sciences and TheraVida, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Develop drugs for genitourinary (GU) disorders
|
|
| domain | founded_year | HQ Location |
Lipid-based therapies for common bladder syndromes are developed.
|
|
| domain | founded_year | HQ Location |
Therapies for renal diseases and urology-related anemia are developed.
|
|
| domain | founded_year | HQ Location |
Male contraception procedures are developed via Vasalgel technology.
|
|
| domain | founded_year | HQ Location |
Clinical stage biopharma company developing drugs for urology and central nervous system disorders
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Regenfro Co
Frequently Asked Questions about Regenfro Co
When was Regenfro Co founded?
Regenfro Co was founded in 2019 and raised its 1st funding round 3 years after it was founded.
Where is Regenfro Co located?
Regenfro Co is headquartered in Kyoto, Japan. It is registered at Kyoto, Kyoto Prefecture, Japan.
Who is the current CEO of Regenfro Co?
Akifumi Morinaka is the current CEO of Regenfro Co.
Is Regenfro Co a funded company?
Regenfro Co is a funded company, having raised a total of $28.88M across 2 funding rounds to date. The company's 1st funding round was a Series A of $12.08M, raised on Jan 31, 2022.
What does Regenfro Co do?
Developer of therapeutics to treat renal diseases. The company has developed stem cell-based regenerative therapeutic products such as patent-pending nephron progenitor cells for renal cells, patented erythropoietin-producing cells for renal anemia, and urethroplasty for the development of kidney organoids.
Who are the top competitors of Regenfro Co?
Regenfro Co's top competitors include Lipella, Kissei Pharmaceutical and Esprit Pharma.
Who are Regenfro Co's investors?
Regenfro Co has 21 investors. Key investors include Sumitomo Mitsui Banking Corporation, MITSUI CHEMICALS, Shimadzu Corporation, Asahi Kasei, and m3.com.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.